Independent Director · Syndax Pharmaceuticals Inc (SNDX)

Chair, Compensation Committee

Keith A. Katkin director compensation at Syndax Pharmaceuticals: $511K

Fiscal year 2025 director compensation for Keith A. Katkin at Syndax Pharmaceuticals Inc. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 30, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Keith A. Katkin’s full pay file as a PDF — free

More than this page: up to 10 years of Keith’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Keith A. Katkin and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Syndax Pharmaceuticals Director Compensation Table · all 4 fiscal years held
In US dollars, as Syndax Pharmaceuticals reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$145,000$366,250$0$0$511,250
FY2024$128,433$378,760——$507,193
FY2022$120,215$252,640——$372,855
FY2021$100,464$341,760——$442,224

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Syndax Pharmaceuticals Inc DEF 14A filed April 30, 2026, accession 0001193125-26-197859, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Syndax Pharmaceuticals Inc filed document, accession 0001193125-26-197859. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2026.

Get the Syndax Pharmaceuticals Board Governance Report

$511,250 Keith A. Katkin, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 30, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Syndax Pharmaceuticals pays directors a $50,000 cash retainer and $366,250 in equity.

Committees

FY2025 · as the proxy prints them

Audit · Compensation (Chair)

The rest of the Syndax Pharmaceuticals board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Aleksandra Rizo, M.D., Ph.DIndependent Director$426,250
Dennis G. PodlesakChair of the Board$947,000
Jennifer JarrettIndependent Director$433,750
Martin H. Huber, M.DIndependent Director$433,750
Michael A. MetzgerDirector—
Pierre LegaultIndependent Director$503,750

The full Syndax Pharmaceuticals compensation record

free company brief

This page is one director within Syndax Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the Syndax Pharmaceuticals proxy · each links to its own free brief

Order SNDX

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report